- Home
- BAX vs DKNG Comparison
BAX vs DKNG Comparison
Compare BAX & DKNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BAX | DKNG |
|---|---|---|
| Founded | 1931 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3B | 13.0B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BAX | DKNG |
|---|---|---|
| Price | $26.47 | $19.36 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 37 |
| Target Price | ★ $27.25 | $27.09 |
| AVG Volume (30 Days) | 7.2M | ★ 14.4M |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | ★ 0.15% | N/A |
| EPS Growth | N/A | ★ 99.05 |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $11,244,000,000.00 | $6,054,525,000.00 |
| Revenue This Year | $4.27 | $7.16 |
| Revenue Next Year | $2.01 | $16.19 |
| P/E Ratio | $34.07 | ★ N/A |
| Revenue Growth | 5.72 | ★ 26.99 |
| 52 Week Low | $15.73 | $16.55 |
| 52 Week High | $30.00 | $36.98 |
Technical Indicators
Market Signals| Indicator | BAX | DKNG |
|---|---|---|
| Relative Strength Index (RSI) | 59.46 | 42.54 |
| Support Level | $25.75 | $18.45 |
| Resistance Level | $30.00 | $24.48 |
| Average True Range (ATR) | 1.17 | 1.07 |
| MACD | 0.18 | -0.12 |
| Stochastic Oscillator | 85.19 | 37.63 |
Price Performance
Historical ComparisonAbout BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
About DKNG DraftKings Inc.
DraftKings got its start in 2012 as an innovator in daily fantasy sports. Then, following a Supreme Court ruling in 2018 that allowed states to legalize online sports wagering, the company expanded into online sports and casino gambling, where it generally holds the number-two or -three revenue share position across states where it competes. With its predictive market launch in 2025, DraftKings is now live with online or retail sports betting in most all states and i-gaming in five states, with both products available to about 50% of Canada's population. In 2025, sports revenue was 63% of total sales, i-gaming 30%, and fantasy and lottery 7%.